Skip to main content
Log in

Aripiprazole augmentation worth it in treatment-resistant depression

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Yoon J, et al. Comparing Cost-Effectiveness of Aripiprazole Augmentation With Other "Next-Step" Depression Treatment Strategies: A Randomized Clinical Trial. Journal of Clinical Psychiatry 80: No. 1, Jan 2019. Available from: URL: https://doi.org/10.4088/JCP.18m12294

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aripiprazole augmentation worth it in treatment-resistant depression. PharmacoEcon Outcomes News 821, 7 (2019). https://doi.org/10.1007/s40274-019-5624-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5624-0

Navigation